Dual targeting of DNA damage repair pathway by BET and CDK4/6 inhibitors synergistically inhibits breast cancer

被引：0
|
作者：
Chi, S. [1 ]
Wei, F. [1 ]
Fang, Y. [1 ]
Hu, Y. [1 ,2 ]
Duan, W. [1 ,2 ]
Ding, J. [1 ,2 ]
Chen, Y. [1 ,2 ]
机构：
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China
[2] Shandong Lab Yantai Drug Discovery, Bohai Rim Adv Res Inst Drug Discovery, Yantai, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 211卷
关键词：
D O I：
10.1016/j.ejca.2024.114732
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PB202
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [31] Advances in CDK4 and 6 Inhibitors: Transforming Breast Cancer Treatment
    Ballestin, Sonia Santander
    Labena, Maria Abadia
    Avedillo-Salas, Ana
    Continente, Cristina Marco
    Blazquez, Marina Arribas
    Bartolome, Maria Jose Luesma
    CANCERS, 2025, 17 (05)
  • [32] Combined inhibition of CDK2 and CDK4/6 overcomes acquired resistance to CDK4/6 inhibitors in breast cancer via RB-independent pathway
    Pandey, Kamal
    CANCER RESEARCH, 2020, 80 (16)
  • [33] Current Therapeutic Progress of CDK4/6 Inhibitors in Breast Cancer
    Wu, Yanmei
    Zhang, Yu
    Pi, Hao
    Sheng, Yuan
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3477 - 3487
  • [34] Position paper on CDK4/6 inhibitors in early breast cancer
    Gnant, Michael
    Singer, Christian F.
    Rinnerthaler, Gabriel
    Pfeiler, Georg
    Egle, Daniel
    Balic, Marija
    Bartsch, Rupert
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (02) : 135 - 144
  • [35] Accessibility of CDK4/6 inhibitors for breast cancer patients in the Netherlands
    Luyendijk, Marianne
    Blommestein, Hedwig
    Jager, Agnes
    Siesling, Sabine
    Uyl-de Groot, Carin
    CANCER RESEARCH, 2022, 82 (04)
  • [36] Cardiac complications of CDK4/6 inhibitors for breast cancer.
    Master, Samip R.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] CDK4/6 Inhibitors : Promising Opportunities beyond Breast Cancer
    Lim, Joline S. J.
    Turner, Nicholas C.
    Yap, Timothy A.
    CANCER DISCOVERY, 2016, 6 (07) : 697 - 699
  • [38] An Update on the Clinical Use of CDK4/6 Inhibitors in Breast Cancer
    Robert, Marie
    Frenel, Jean-Sebastien
    Bourbouloux, Emmanuelle
    Rigaud, Dominique Berton
    Patsouris, Anne
    Augereau, Paule
    Gourmelon, Carole
    Campone, Mario
    DRUGS, 2018, 78 (13) : 1353 - 1362
  • [39] Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer
    George, Mridula A.
    Qureshi, Sadaf
    Omene, Coral
    Toppmeyer, Deborah L.
    Ganesan, Shridar
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] CDK4/6 inhibitors in advanced breast cancer, what is beyond?
    Mohammed, Amrallah A.
    Rashied, Hanaa
    Elsayed, Fifi Mostafa
    ONCOLOGY REVIEWS, 2019, 13 (02) : 125 - 133
12345